Potential errors in measuring the phase difference between chest flow and mouth flow.

M Mishima; K Kawakami; N Sugiura; T Fukunaga; N Sakai; T Hirai; K Kuno

Home/Archive/PubMed

PubMed · 8280667

Potential errors in measuring the phase difference between chest flow and mouth flow.

M Mishima·K Kawakami·N Sugiura·T Fukunaga·N Sakai·T Hirai·K Kuno

View original source ↗Export metadata ↓

Abstract

We have previously reported that the phase difference between chest and mouth flows was a useful indicator of obstructive lung disease. In this paper, we calculated the effects of (i) airway reactance, (ii) extrathoracic airway shunt impedance, (iii) heating and humidification of the inspired air, (iv) abdominal gas volume, and (v) respiratory quotient on the measurement of the phase difference between chest flow (Vc) and mouth flow (Vm) using computer simulations. When the airway impedance was approximated as simple airway resistance, the phase difference (theta r) was calculated to be 0.8% less than the phase difference (theta s) calculated from the airway impedance (Za), including airway inertance and shunt compliance, in the normal lung. theta s became larger than theta r when the peripheral resistance increased, but did not exceed 5%. The extrathoracic airway shunt impedance effect did not exceed 0.1%, regardless of the respiratory frequency, airway impedance or thoracic gas volume. The influence of heating and humidification of the inspired air on the phase difference was calculated to be within 5%. The effect of abdominal gas was highly dependent on the abdominal gas volume and the respiratory pattern, but was calculated to be within 5%. The influence of the respiratory quotient was calculated to be negligible. As a result, it was concluded that none of the factors discussed above are an obstacle to the clinical application of this method for the evaluation of pathological changes in obstructive airway disorders.

Explore related subjects

Airway Resistance Computer Simulation Gases Humans Intestines Models, Biological Mouth Pulmonary Ventilation Reference Values Thorax Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

M Mishima, K Kawakami, N Sugiura, T Fukunaga, N Sakai, T Hirai, K Kuno. 1993. Potential errors in measuring the phase difference between chest flow and mouth flow.. https://pubmed.ncbi.nlm.nih.gov/8280667/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Upper airway resistance syndrome: effect of nasal dilation, sleep stage, and sleep position.

BACKGROUND: The upper airway resistance syndrome (UARS) is one of the mild variants of obstructive sleep disordered breathing. Nasal obstruction is proposed as one of the mechanisms that lowers intrapharyngeal pressure and hence increases airway collapsibility. OBJECTIVE: We evaluated the effect of external nasal dilation and sleep position on sleep in UARS. METHOD: A double blind, randomized, controlled study with a crossover design (using therapeutic and placebo dilators) was conducted in 18 consecutive patients with UARS. Each patient had two overnight sleep studies one to two weeks apart. Cardiorespiratory parameters (AHI, percentage of time that SaO2 was more than 2% below awake [desaturation time] and mean overnight heart rate), sleep architecture (sleep stages, sleep efficiency, and arousal index), and body position were determined. RESULTS: Application of the external nasal dilator resulted in a significant increase in the nasal cross-sectional area (p < 0.001). Treatment reduced stage 1 sleep (as a percent of total sleep time) from 8.6 +/- 0.8% to 7.1 +/- 0.7 (SEM), p = 0.034). Desaturation time was significantly lower with treatment (12.2 +/- 2.2% on placebo versus 9.1 +/- 1.3 on treatment, p = 0.04). There were no additional significant effects on the cardiorespiratory parameters, sleep architecture, or MSLT when the entire night was examined. Controlling for interactions of sleep stage and position and treatment we found that treatment reduced desaturation time (p = 0.03) but not AHI or arousal index. AHI was significantly lower in the lateral position compared to the supine (p = 0.0001) and in NREM sleep compared to REM (p = 0.001). Desaturation time was significantly lower on the lateral compared to the supine position (p = 0.002) and in NREM sleep compared to REM (p = 0.006). Arousal index was highly dependent on sleep stage (p = 0.0001): the index was higher in stage 2 compared to slow wave sleep and REM. Sleep position and treatment had no significant effect on arousals. CONCLUSIONS: External nasal dilation reduced stage 1 sleep, an indirect marker of disrupted sleep, and desaturation time. There were no additional effects on sleep architecture or sleep disordered breathing. Both sleep position and sleep stage had a significant effect on sleep disordered breathing in UARS.

Airway Resistance↗

PubMed1999

Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs.

We examined the effect of a specific cysteinyl leukotriene (LT) receptor antagonist, 4-oxo-8-[4-(4-phenylbutoxy)benzoylamino]-2-(tetrazol-5-yl)-4 H-1-benzopyran hemihydrate (pranlukast), on a novel model of allergic rhinitis induced by repeated intranasal ovalbumin challenge in actively sensitized guinea pigs. Repeated intranasal ovalbumin challenge caused a biphasic increase of nasal airway resistance, peaking 0.5 and 4 h after the final challenge. The early-phase response was accompanied by an increase in sneezing and nasal secretion, while that in the late phase was associated with edema and eosinophil infiltration of the nasal mucosa. Analysis of nasal lavage fluid showed that cysteinyl LTs increased in both phases. Pranlukast, when administered 1 h before every ovalbumin challenge, dose-dependently suppressed the increase of nasal airway resistance in the early- and late phase with evidence of histopathological improvements in the late phase. Pranlukast, however, failed to suppress sneezing and nasal secretion. We suggest that cysteinyl LTs play an important role in allergic rhinitis especially in the nasal obstruction due to edema of the nasal mucosa membrane.

Airway Resistance↗

PubMed1999

A dynamic and direct visualization model for the study of nasal airflow.

OBJECTIVE: To evaluate nasal airflow characteristics during physiologic breathing in normal and pathologic conditions. DESIGN: The choana of an anatomical human model was connected to a pump that simulated physiological pressure changes in the upper airway system. Normal ambient air was used as medium. The airstream was marked with aerosolized water particles, and was observed through an exact but translucent replica of the original nasal septum. RESULTS: In physiologic conditions the airflow is mixed. Turbulence is clearly visible even with low flow velocities. There is less turbulence with lower flow rates. The nasal airflow follows a triphasic pattern of acceleration, near-steady state, and deceleration. Turbulence is prominent in the first and third phases. The main flow stream passes through the middle meatus at all rates. Hypertrophic mucosal membranes and turbinates increase the proportion of air passing the middle meatus. With decongested turbinates, flow distribution is more even. After turbinectomy there is a significant amount of airflow passing along the floor of the nose. The olfactory region is aerated only toward the end of inspiration and during the entire expiration phase. CONCLUSIONS: This model allows the investigation of airflow distribution and turbulence under physiologic conditions and the examination of the influence of pathologic conditions on these parameters. Overzealous trimming of turbinates results in an unphysiologic distribution of airflow.

Airway Resistance↗